Medtronic Inc (MDT) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Medtronic Inc (MDT)

82.08

+1.39 (1.72%)

as of Jun 9, 2026, 2:36:10 pm Market Open.

181 watching

Investor Insights

Jun 9, 2026, 12:00 am

This summary was created by AI, based on 2 opinions in the last 12 months.

Medtronic Inc. (MDT) appears to have a positive outlook in the short to medium-term, as noted by experts. One reviewer emphasized that the company's positioning to benefit from AI advancements and the ongoing support from the Baby Boomer demographic could serve as significant tailwinds. However, another expert pointed out that although Medtronic is diversified and not solely focused on knee devices, it still lacks the R&D strength to outpace competitors like Boston Scientific. The company's recent product launches and an attractive price-to-earnings ratio suggest potential price appreciation over the next 12 to 18 months. Ultimately, while there are short-term opportunities, there is skepticism regarding long-term investment, indicating a nuanced view on the company's future growth prospects.

Consensus

Positive

Valuation

Undervalued

Similar

Stryker,SYK

TOP PICK

He has a model price of $41.29 giving it a 21% positive differential. Just reported greater earnings. 2% yield.

BUY

Likes medical devices sector. Of all the sectors, medical equipment is one of the tops. Regardless of what is going on in the economies , medical devices will continue to sell. He owns Zoll Medical (ZOLL-Q) instead, which has more growth potential. Thinks there is more upside potential in the small/mid-cap size names.

BUY

PE of about 20 and anticipated growth rate of about 14%. Have a lot of intellectual property. Reasonably attractive.

DON'T BUY

His model price is $41.45 so it is a negative 23%-24% differential. This is one of those stocks that is perpetually overvalued.

BUY

Likes a lot of the big US healthcare stocks. Valuation is reasonable.

BUY ON WEAKNESS

On his watch list as a possible investment. Valuation has been hurt but the fundamentals have not changed much. The long-term outlook for their products is very good.

TOP PICK

A high quality, growth company. Good price. The leading medical technology company in the world.

TOP PICK

Solid earnings. Feels their new stent will be successful next year.

DON'T BUY

Interesting company. Market is very strong for their products. Stock isn't cheap. Has been growing slowely

DON'T BUY

Valuation is a little bit ahead of the stock. Very good management.

DON'T BUY

Competition. Too expensive at 30 X earnings.

BUY ON WEAKNESS

Great company. Buy in the mid to low $20's.

TOP PICK

Good company. Not a cheap stock. A cash machine.

BUY

Good price now. Good mngmnt.

PAST TOP PICK

Good acquisition. Fairly expensive, but the dominant player. No debt. Good dividends.

Showing 106 to 120 of 125 entries

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Most Recent Experts

Barry Schwartz

Baskin Wealth Management

Jim Cramer - Mad Money

CNBC

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Mike Vinokur, CFA, CMT, and CFP

Propellus Wealth Partners/iA Private Wealth

Brian Madden

First Avenue Investment Counsel

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Medtronic Inc (MDT)